Abstract:
Antiphospholipid syndrome (APS) is one of the leading causes of thrombosis. According to
some estimates, the incidence of APS is about 5 new cases per 100,000 people per year and
the prevalence is about 40-50 cases per 100,000 people [1], thus the problem of APS remains
one of the most important in medicine.